Paul Sauer - 22 Mar 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Process Dev, Manufacturing
Signature
/s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
22 Mar 2022
Net transactions value
-$75,000
Form type
4
Filing time
24 Mar 2022, 18:05:46 UTC
Previous filing
14 Mar 2022
Next filing
26 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $75,000 -3,000 -9.6% $25.00 28,125 22 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.